Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 173, Issue 5, Pages 856-869
Publisher
Wiley
Online
2015-11-25
DOI
10.1111/bph.13394
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation
- (2016) Anja Henn ALTEX-Alternatives to Animal Experimentation
- The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors
- (2015) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP
- (2015) John C McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling
- (2015) A L Northcutt et al. MOLECULAR PSYCHIATRY
- TRIF and IRF-3 Binding to the TNF Promoter Results in Macrophage TNF Dysregulation and Steatosis Induced by Chronic Ethanol
- (2014) X.-J. Zhao et al. JOURNAL OF IMMUNOLOGY
- PTX3 Binds MD-2 and Promotes TRIF-Dependent Immune Protection in Aspergillosis
- (2014) Silvia Bozza et al. JOURNAL OF IMMUNOLOGY
- An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
- (2014) Y. Zhang et al. JOURNAL OF NEUROSCIENCE
- Emerging targets in neuroinflammation-driven chronic pain
- (2014) Ru-Rong Ji et al. NATURE REVIEWS DRUG DISCOVERY
- Lipopolysaccharide differentially modulates expression of cytokines and cyclooxygenases in dorsal root ganglion cells via Toll-like receptor-4 dependent pathways
- (2014) K.-H. Tse et al. NEUROSCIENCE
- In vivo veritas: (+)-Naltrexone's actions define translational importance
- (2014) Linda R. Watkins et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Effect of Chronic Delivery of the Toll-like Receptor 4 Antagonist (+)-Naltrexone on Incubation of Heroin Craving
- (2013) Florence R. Theberge et al. BIOLOGICAL PSYCHIATRY
- Targeting Toll-like receptors with small molecule agents
- (2013) Xiaohui Wang et al. CHEMICAL SOCIETY REVIEWS
- Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain
- (2013) Xiaohui Wang et al. FASEB JOURNAL
- Brain microglia: watchdogs with pedigree
- (2013) Harald Neumann et al. NATURE NEUROSCIENCE
- Why is neuroimmunopharmacology crucial for the future of addiction research?
- (2013) Mark R. Hutchinson et al. NEUROPHARMACOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Reactive oxygen species contribute to neuropathic pain and locomotor dysfunction via activation of CamKII in remote segments following spinal cord contusion injury in rats
- (2013) Young S. Gwak et al. PAIN
- Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4
- (2012) CW Stevens et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting Interleukin-1β for Pain
- (2012) Sivaram Pillarisetti CNS & Neurological Disorders-Drug Targets
- Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91 phox subunit of NADPH oxidase
- (2012) Qingshan Wang et al. Journal of Neuroinflammation
- Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
- (2012) M. R. Hutchinson et al. JOURNAL OF NEUROSCIENCE
- (+)-Naloxone, an Opioid-Inactive Toll-Like Receptor 4 Signaling Inhibitor, Reverses Multiple Models of Chronic Neuropathic Pain in Rats
- (2012) Susannah S. Lewis et al. JOURNAL OF PAIN
- Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence
- (2012) Janet K. Coller et al. PHARMACOLOGY & THERAPEUTICS
- Morphine activates neuroinflammation in a manner parallel to endotoxin
- (2012) X. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sex and estradiol influence glial pro-inflammatory responses to lipopolysaccharide in rats
- (2012) Lisa C. Loram et al. PSYCHONEUROENDOCRINOLOGY
- Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist
- (2012) W. S. Bowen et al. Science Signaling
- LPS Sensitizes TRPV1 via Activation of TLR4 in Trigeminal Sensory Neurons
- (2011) A. Diogenes et al. JOURNAL OF DENTAL RESEARCH
- Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release
- (2011) June Yowtak et al. PAIN
- Exploring the Neuroimmunopharmacology of Opioids: An Integrative Review of Mechanisms of Central Immune Signaling and Their Implications for Opioid Analgesia
- (2011) M. R. Hutchinson et al. PHARMACOLOGICAL REVIEWS
- Toll-like receptor signaling in neural plasticity and disease
- (2011) Eitan Okun et al. TRENDS IN NEUROSCIENCES
- Application of a novel in silico high-throughput screen to identify selective inhibitors for protein–protein interactions
- (2010) Catherine Joce et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- TNF-α and neuropathic pain - a review
- (2010) Lawrence Leung et al. Journal of Neuroinflammation
- A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
- (2010) H. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selection, Preparation, and Evaluation of Small-Molecule Inhibitors of Toll-Like Receptor 4
- (2010) Douglas E. Bevan et al. ACS Medicinal Chemistry Letters
- Evidence that opioids may have toll-like receptor 4 and MD-2 effects
- (2009) Mark R. Hutchinson et al. BRAIN BEHAVIOR AND IMMUNITY
- CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar A -Stimulated Microglial Activation
- (2009) E. G. Reed-Geaghan et al. JOURNAL OF NEUROSCIENCE
- Naloxone's Pentapeptide Binding Site on Filamin A Blocks Mu Opioid Receptor–Gs Coupling and CREB Activation of Acute Morphine
- (2009) Hoau-Yan Wang et al. PLoS One
- No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing
- (2009) Achim Schmidtko et al. TRENDS IN NEUROSCIENCES
- Modulation of Opioid Actions by Nitric Oxide Signaling
- (2008) Noboru Toda et al. ANESTHESIOLOGY
- Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)
- (2008) Mark R. Hutchinson et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system
- (2008) Ryan N. Dilger et al. JOURNAL OF LEUKOCYTE BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started